Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cellsAndrea Ghelli Luserna di Rorà, Giorgia Simonetti, Maria Teresa Bochicchio et al.|Cell Biology and Toxicology|2021Cited by 28
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic LeukemiaAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Matteo Bocconcelli et al.|Cancers|2019Cited by 27
PF169 LONG‐TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTSAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Matteo Bocconcelli et al.|HemaSphere|2019Cited by 0
Abstract 2964: Pharmacological inhibition of WIP1 by GSK2830371 sensitizes AML cells to MDM2 inhibitor Nutlin-3aMaria Chiara Fontana, Giovanni Martinelli, Jacopo Nanni et al.|Cancer Research|2019Cited by 0
Abstract 2964: Pharmacological inhibition of WIP1 by GSK2830371 sensitizes AML cells to MDM2 inhibitor Nutlin-3aMaria Chiara Fontana, Giovanni Martinelli, Jacopo Nanni et al.|Experimental and Molecular Therapeutics|2019Cited by 0